Multi Medika (Indonesia) Management Evaluation
MMIX Stock | 75.00 1.00 1.32% |
Multi Medika employs about 63 people. The company is managed by 5 executives with a total tenure of roughly 147 years, averaging almost 29.0 years of service per executive, having 12.6 employees per reported executive. Inspection of Multi Medika's management performance can provide insight into the company performance.
Eveline Susanto Insider CoFounder CFO |
Mengky Mangarek Insider Founder Director |
Multi |
Multi Medika Workforce Comparison
Multi Medika Internasional is regarded fourth in number of employees category among its peers. The total workforce of Pharmaceutical Retailers industry is now estimated at about 1,229. Multi Medika holds roughly 63.0 in number of employees claiming about 5% of equities listed under Pharmaceutical Retailers industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18. Multi Medika Interna Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Multi Medika Interna Price Series Summation is a cross summation of Multi Medika price series and its benchmark/peer.
Multi Medika Notable Stakeholders
A Multi Medika stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Multi Medika often face trade-offs trying to please all of them. Multi Medika's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Multi Medika's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eveline Susanto | CoFounder CFO | Profile | |
Mengky Mangarek | Founder Director | Profile | |
Karina Nurhadiah | Co Sec | Profile | |
Christopher Lee | Chief Officer | Profile | |
Jacky Raharja | Chief Officer | Profile |
About Multi Medika Management Performance
The success or failure of an entity such as Multi Medika Interna often depends on how effective the management is. Multi Medika management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Multi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Multi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Multi Medika Workforce Analysis
Traditionally, organizations such as Multi Medika use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Multi Medika within its industry.Multi Medika Manpower Efficiency
Return on Multi Medika Manpower
Revenue Per Employee | 2.9B | |
Revenue Per Executive | 36.4B |
Other Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.